ArticleAntimicrobial agents and chemotherapy2010

Validation of the INNO-LiPA HBV DR assay (version 2) in monitoring hepatitis B virus-infected patients receiving nucleoside analog treatment.

H G M Niesters et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.